Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series | Zendy

Ozden Muge G. | Zendy; Ozdemir Hilal | Zendy; Şenturk Nilgun | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series

Author(s) -

Ozden Muge G.,

Ozdemir Hilal,

Şenturk Nilgun

Publication year - 2020

Publication title -

dermatologic therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.595

H-Index - 68

eISSN - 1529-8019

pISSN - 1396-0296

DOI - 10.1111/dth.13229

Subject(s) - medicine , intravenous immunoglobulins , antibody , retrospective cohort study , surgery , gastroenterology , dermatology , immunology

We report a retrospective analysis the efficacy of high‐dose intravenous immunoglobulins on 9 patients with Livedoid vasculopathy for whom resistant to immunosuppressants plus anticoagulants or could not be prescribed. Intravenous immunoglobulins were used 2 g/kg per month in these patients. The treatment induced stabilization of the disease and all patients demonstrated improvement with IVIg. Complete and partial clinical response was achieved in 6 and 3 patients respectively.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research